Effects of Polyunsaturated Fatty Acids on Liver Cancer Cells
Author Information
Author(s): Maria Notarnicola, Caterina Messa, Maria G. Refolo, Valeria Tutino, Angelica Miccolis, Maria G. Caruso
Primary Institution: Laboratory of Biochemistry, National Institute for Digestive Diseases, Castellana Grotte (BA), Italy
Hypothesis
How do eicosapentaenoic acid (EPA) and arachidonic acid (ARA) affect the growth and apoptosis of HepG2 liver cancer cells?
Conclusion
EPA and ARA inhibit the growth of HepG2 liver cancer cells and promote apoptosis by down-regulating specific gene expressions.
Supporting Evidence
- EPA inhibits HepG2 cell growth in a dose-dependent manner starting from 25 μM.
- A statistically significant pro-apoptotic effect of EPA is observed at 1 μM.
- Higher doses of ARA are needed to achieve significant effects compared to EPA.
- Down-regulation of FAS and HMG-CoAR gene expression starts at 10 μM of EPA and ARA.
Takeaway
Eating certain fats can help stop liver cancer cells from growing and can even make them die.
Methodology
HepG2 cells were treated with varying concentrations of EPA and ARA for 48 hours, followed by assays for cell growth and apoptosis, and gene expression analysis using PCR.
Limitations
The study is based on in vitro results, which may not directly translate to clinical outcomes.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website